DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR SAXAGLIPTIN HYDROCHLORIDE

« Back to Dashboard

All Clinical Trials for Saxagliptin Hydrochloride

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00121641	Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise	Completed	AstraZeneca	Phase 3	2005-07-01	The purpose of this clinical research study is to learn whether saxagliptin (BMS-477118) is more effective than placebo as a treatment for type 2 diabetic subjects who are not sufficiently controlled with diet and exercise
NCT00121667	Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone	Completed	AstraZeneca	Phase 3	2005-08-01	The purpose of this clinical research study is to learn whether Saxagliptin added to Metformin therapy is more effective than Metformin alone as a treatment for type 2 diabetic subjects who are not sufficiently controlled with Metformin alone
NCT00295633	A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone	Completed	AstraZeneca	Phase 3	2006-03-01	The purpose of this clinical research study is to learn whether Saxagliptin added to thiazolidinedione (TZD) therapy is more effective than TZD alone as a treatment for Type 2 diabetic subjects who are not sufficiently controlled with TZD alone
NCT00313313	A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas	Completed	AstraZeneca	Phase 3	2006-04-01	The purpose of this trial is to understand if adding saxagliptin to a sulfonylurea is safe and works better than increasing the amount of sulfonylurea a patient takes
NCT00316082	Study of BMS-477118 as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise	Completed	AstraZeneca	Phase 3	2006-06-01	The purpose of this trial is to understand if saxagliptin is more effective than placebo as a treatment for type 2 diabetic subjects who are not controlled with diet and exercise

Clinical Trial Conditions for Saxagliptin Hydrochloride

Condition Name

Condition Name for Saxagliptin Hydrochloride
Intervention	Trials
Type 2 Diabetes Mellitus	32
Type 2 Diabetes	30
Diabetes Mellitus, Type 2	16
Diabetes	6

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Saxagliptin Hydrochloride
Intervention	Trials
Diabetes Mellitus, Type 2	90
Diabetes Mellitus	85
Glucose Intolerance	5
Diabetes Mellitus, Type 1	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Saxagliptin Hydrochloride

Trials by Country

Trials by Country for Saxagliptin Hydrochloride
Location	Trials
United States	476
Canada	79
Mexico	67
India	44
China	44

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Saxagliptin Hydrochloride
Location	Trials
Texas	34
California	27
Florida	22
Ohio	20
South Carolina	18

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Saxagliptin Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Saxagliptin Hydrochloride
Clinical Trial Phase	Trials
Phase 4	38
Phase 3	41
Phase 2/Phase 3	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Saxagliptin Hydrochloride
Clinical Trial Phase	Trials
Completed	65
Recruiting	23
Not yet recruiting	13

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Saxagliptin Hydrochloride

Sponsor Name

Sponsor Name for Saxagliptin Hydrochloride
Sponsor	Trials
AstraZeneca	71
Bristol-Myers Squibb	17
Canadian Institutes of Health Research (CIHR)	3

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Saxagliptin Hydrochloride
Sponsor	Trials
Industry	92
Other	87
NIH	1

Export unavailable in trial.
Subscribe for complete access.